Login
Navigate Fool.com
Will ENTA beat
the market?
Community Rating: 3 Stars: Appealing

33.39 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.10
Previous Close $33.39
Daily Range $32.64 - $33.93
52-Week Range $16.18 - $43.73
Market Cap $613.2M
P/E Ratio -13.69
Dividend (Yield) $0.00 (0.0%)
Volume 266,164
Average Daily Volume 328,581
Current FY EPS $1.47

How do you think ENTA
will perform against the market?

Top ENTA Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Today's Biotech Stocks to Watch: AbbVie Inc., Enanta Pharmaceuticals Inc. and Gilead Sciences

Today's top stories in health care and biotech.

Has A Streamlined FDA Raised The Value Of Drug Stocks?

Today's Biotech Stocks to Watch: Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Inc.

Morning movers in biotech and health care.

Why Enanta Pharmaceuticals, Inc. Should Be on Your Watchlist

Enanta Pharmaceuticals and its collaborator AbbVie are inching closer to a regulatory filing for their hepatitis C drug. Here is what you need to know heading into this event.

This Small Biotech Will Profit From the Hep C Drug Race

Gilead and AbbVie are set to gain the most from developing new hepatitis C cocktails; Enanta Pharmaceuticals will benefit from AbbVie's sales.

Commit To Purchase Enanta Pharmaceuticals At $35, Earn 20.7% Annualized Using Options

Sector Update: Healthcare

Sector Update: Healthcare Shares Fairly Flat; Acorda Q4 Earnings Top Street View

Biotech Losers: InterMune, Enanta, and GW Pharmaceuticals

Here's what dragged down InterMune, Enanta, and GW Pharmaceuticals in the biotech space this week.

AbbVie's Challenge to Gilead in Hepatitis C Therapies

New clinical data from AbbVie spice up hepatitis C market and prospects for the company

See More ENTA News...

Sector

Industry

Enanta Pharmaceuticals, Inc. (ENTA) Description

Enanta Pharmaceuticals, Inc. Website: http://www.enanta.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks